Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70010-784

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70010-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-150-30s-label-jpg (Bupropion 150 30s Label Jpg)

NDC 70010-784-03 prescription medicine with 150 mg Once-Daily bupropion hydrochloride, USP. The suggested dosage is one tablet daily or as directed. This extended-release medication should be stored at a temperature of 25°C (77°F). Do not use in combination with Zyban or similar medicines. Keep out of reach of children. Additional medication guides are available at granulesindia.com/U.S.ProductCatalog.php. This medication guide should be given to each patient. Manufactured by Granules Pharmaceuticals Inc. with 30 tablets each. Rev.0721.*

FDA Label Image

Bupropion-300-30s-label-jpg (Bupropion 300 30s Label Jpg)

Each extended-release tablet contains 300mg of Once-Daily bupropion hydrochloride, USP. It is advised to store the tablets at 5°C (77°F) with excursions permitted. Keep the tablets and all medications out of the reach of children. It is recommended not to use this medication in combination with Zyban® or any other medicines containing bupropion hydrochloride. Dispense the enclosed medication guide to each patient. For additional medication guides, visit http:/iwww.granulesindia.com/U.S.ProductCatalog.php.*

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.